Oxford Nanopore Technologies
Oxford Nanopore has developed a new generation of DNA/RNA sequencing technology. It is the only sequencing technology that offers real-time analysis in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths.
Latest Oxford Nanopore Technologies Content
Product News
Oxford Nanopore and Day Zero Diagnostics Partner To Develop a New Class of Bloodstream Infection Diagnostics
Oxford Nanopore, and Day Zero Diagnostics (DZD), announced a collaboration to develop an end-to-end solution for the diagnosis of bloodstream infections, a leading cause of sepsis.
Product News
Oxford Nanopore To Showcase What You’re Missing Matters When Investigating Disease Enabled by Nanopore Sequencing
Our packed agenda will highlight how the Oxford Nanopore platform can generate richer data revealing enhanced biological insights not possible with short read sequencing – or other sequencing platforms – to accelerate research into human disease.
Product News
Oxford Nanopore Technologies and Fabric Genomics Collaborate To Launch an Integrated Whole-Genome Sequencing Solution
The partners will offer an integrated sample-to-report rapid nanopore sequencing analysis platform for neonatal/paediatric intensive care units to support clinicians in acute settings.
Product News
Oxford Nanopore Meets Apple’s M3 Silicon Chip
CEO Gordon Sanghera discusses how Apple’s latest product announcement means complex processing required for DNA/RNA sequencing can now be run from the latest MacBook Pro™ or iMac ™.
Product News
bioMérieux Makes Strategic Investment in Oxford Nanopore
Oxford Nanopore Technologies, announce that bioMérieux is making an immediate £70M investment in Oxford Nanopore.
Product News
Mayo Clinic and Oxford Nanopore Announce Collaboration
Joint development collaboration to bring leading-edge nanopore sequencing into clinical laboratories at Mayo Clinic to increase understanding and improve treatment of cancer and genetic disorders.
News
Bats’ Genomes Protect Them From Viruses and Cancer
Bats have acquired remarkable traits throughout their evolution. But perhaps most impressive is their robust immune system. It protects bats from viruses that wreak havoc in humans, like COVID-19 or Ebola.
Webinar
Parent-of-Origin Genome Analysis: The Potential To Improve Genetic Testing
On-Demand
This webinar will introduce a novel method for parent-of-origin-aware genomic analysis using the long-read capabilities of nanopore sequencing and single-cell DNA template strand sequencing to assign variants to each biological parent with 99% accuracy using only a blood research sample from the child.
App Note / Case Study
Discover the Future of Cancer Research With Whole-Genome Sequencing
To accelerate the discovery of new cancer biomarkers and new insights into the genetics of treatment-resistant tumors, it is crucial to gain a deeper understanding of the genomic and epigenomic variations in cancer.
Webinar
Targeted Nanopore Sequencing for Bacterial and Viral Classification
On-Demand
Amplicon-based sequencing approaches have been widely adopted for routine microbiology applications, including targeted 16S rRNA for bacterial taxonomic classification and tiled multiplex PCR for viral whole-genome sequencing.
Advertisement
